386 related articles for article (PubMed ID: 12200686)
21. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
22. Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid.
Andreeff M; Jiang S; Zhang X; Konopleva M; Estrov Z; Snell VE; Xie Z; Okcu MF; Sanchez-Williams G; Dong J; Estey EH; Champlin RC; Kornblau SM; Reed JC; Zhao S
Leukemia; 1999 Nov; 13(11):1881-92. PubMed ID: 10557066
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
[TBL] [Abstract][Full Text] [Related]
24. Effect of all-trans retinoic acid on chemotherapy induced apoptosis and down-regulation of Bcl-2 in human myeloid leukaemia CD34 positive cells.
Ahmed N; Laverick L; Sammons J; Baumforth KR; Hassan HT
Leuk Res; 1999 Aug; 23(8):741-9. PubMed ID: 10456672
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival.
Moshaver B; van der Pol MA; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Leuk Lymphoma; 2008 Jan; 49(1):134-48. PubMed ID: 17926185
[TBL] [Abstract][Full Text] [Related]
26. [Effect of bone marrow stromal cells on the apoptotic sensitivity of HL-60 and HL-60/VCR cells].
Liang R; Huang GS; Wang Z; Chen XQ; Bai QX; Zhang WP; Wang JH; Wang WQ; Guo Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):286-92. PubMed ID: 15854294
[TBL] [Abstract][Full Text] [Related]
27. BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts.
Kohl TM; Hellinger C; Ahmed F; Buske C; Hiddemann W; Bohlander SK; Spiekermann K
Leukemia; 2007 Aug; 21(8):1763-72. PubMed ID: 17554384
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C.
Keith FJ; Bradbury DA; Zhu YM; Russell NH
Leukemia; 1995 Jan; 9(1):131-8. PubMed ID: 7845007
[TBL] [Abstract][Full Text] [Related]
29. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells].
Lei XY; Zhang H; He DM
Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735
[TBL] [Abstract][Full Text] [Related]
30. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
31. [Effects of bone marrow stromal cells on the chemotherapeutic sensitivity of acute lymphoblastic leukemia cells].
Wang Y; Han ZX; Zhang JC
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):885-890. PubMed ID: 29262503
[No Abstract] [Full Text] [Related]
32. Expression of inducible Bcl-X(S) in myeloid leukemia: compensatory upregulation of Bcl-X(L) and Bcl-2 prevents apoptosis and chemosensitization.
Tacke F; Marini FC; Zhao S; McQueen T; Konopleva M; Ruvolo PP; Hu SX; Xu HJ; Andreeff M
Cancer Biol Ther; 2004 Mar; 3(3):340-7. PubMed ID: 14726688
[TBL] [Abstract][Full Text] [Related]
33. Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells.
Hu ZB; Minden MD; McCulloch EA
Leukemia; 1995 Oct; 9(10):1667-73. PubMed ID: 7564507
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.
Banker DE; Groudine M; Willman CL; Norwood T; Appelbaum FR
Leuk Res; 1998 Mar; 22(3):221-39. PubMed ID: 9619914
[TBL] [Abstract][Full Text] [Related]
35. Stromal-mediated down-regulation of CD13 in bone marrow cells originating from acute myeloid leukemia patients.
Dybkaer K; Olesen G; Pedersen FS; Kristensen JS
Eur J Haematol; 2001 Mar; 66(3):168-77. PubMed ID: 11350485
[TBL] [Abstract][Full Text] [Related]
36. Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis.
Liu N; Wang C; Wang L; Gao L; Cheng H; Tang G; Hu X; Wang J
Int J Mol Med; 2016 Jun; 37(6):1686-96. PubMed ID: 27082972
[TBL] [Abstract][Full Text] [Related]
37. Stromal cell-mediated transcriptional regulation of the CD13/aminopeptidase N gene in leukemic cells.
Saito M; Kumagai M; Okazaki T; Nakazawa S; Shapiro LH; Look AT; Campana D
Leukemia; 1995 Sep; 9(9):1508-16. PubMed ID: 7658720
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia.
Matsunaga T; Fukai F; Miura S; Nakane Y; Owaki T; Kodama H; Tanaka M; Nagaya T; Takimoto R; Takayama T; Niitsu Y
Leukemia; 2008 Feb; 22(2):353-60. PubMed ID: 17972943
[TBL] [Abstract][Full Text] [Related]
39. HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death.
Lickliter JD; Wood NJ; Johnson L; McHugh G; Tan J; Wood F; Cox J; Wickham NW
Leukemia; 2003 Nov; 17(11):2074-80. PubMed ID: 12931228
[TBL] [Abstract][Full Text] [Related]
40. Quantitation of resistance to cytosine arabinoside by myeloid leukemic cells expressing bcl-2.
Guedez L; Suresh A; Tung F; Zucali J
Eur J Haematol; 1996 Aug; 57(2):149-56. PubMed ID: 8856092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]